Clinical Trial Update: Effects of Early Use of Nitazoxanide in Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on early use of nitazoxanide in COVID-19 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Covid19, Coronavirus | Phase 2 | Status: COMPLETED